简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-11-20 10:13 Alibaba Cloud Powered $1B of GMV in 68 Seconds, with Zero Downtime During 11.11
2019-11-20 09:44 Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China
2019-11-18 16:56 QIAGEN Receives Several Conditional, Non-binding Indications of Interest, and Decides to Enter Into Discussions to Explore Potential Strategic Alternatives
2019-11-18 09:48 Ariul Fish LLC of Korea Launches Fish Product 'Golden Tongue Sole' Great for Health in Autumn
2019-11-18 09:46 Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
2019-11-15 13:25 At CIIE 2019 Panasonic Showcases Solutions to Help Bring to Life China's "Healthy China 2030" Vision
2019-11-15 09:40 Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
2019-11-15 09:36 The International Board of Lactation Consultant Examiners (IBLCE) selects Prometric for Global Examination Administration
2019-11-13 19:00 PMC Group Announces Agreement to Acquire Lanxess’ Organotin Specialties Business
2019-11-13 14:34 NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
2019-11-13 12:00 Takeda to Highlight Expanded Portfolio of Products Across Oncology and Hematology at 61st American Society of Hematology (ASH) Annual Meeting
2019-11-13 09:57 Cook Medical’s Leadership Updates in Asia-pacific Reinforce Focus on Growth and Physician Relationships
2019-11-13 09:45 Boehringer Ingelheim and Lilly initiate first ever study to assess empagliflozin in people hospitalised for acute heart failure who have been stabilised
2019-11-11 14:33 Phase 3 Trial of NINLAROTM (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in Multiple Myeloma Patients not treated with Stem Cell Transplantation
2019-11-11 10:31 New Analyses from the Phase 3 HELP Study™ Open-Label Extension in Hereditary Angioedema Evaluate Efficacy and Safety of TAKHZYRO® (lanadelumab-flyo) Injection During Extended Study Treatment Period
2019-11-08 15:50 Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
2019-11-08 15:47 FIND Collaborates with SpeeDx and QuantuMDx
2019-11-08 13:20 Promega Enters Global Collaboration with Merck to Develop Microsatellite Instability (MSI) Companion Diagnostic for Use with KEYTRUDA®
2019-11-07 20:18 Panasonic and Institute of Microchemical Technology Co., Ltd. Jointly Develop Mass Production Technology for Microfluidic Devices by Glass Molding, a First in the Industry*1
2019-11-07 14:29 Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform

Business Wire Weibo

Press Releases

Latest Releases